Canadian headache society guideline for migraine prophylaxis

Canadian Journal of Neurological Sciences

Volumn 39, Issue 2, 2012, Pages

  Pringsheim, Tamara ^a   Davenport, W Jeptha ^a   MacKie, Gordon ^b   Worthington, Irene ^c   Aubé, Michel ^d   Christie, Suzanne N ^e   Gladstone, Jonathan ^f   Becker, Werner J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Richmond Hospital   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e Ottawa Headache Centre   (Canada)

^f Gladstone Headache Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; FLUNARIZINE; GABAPENTIN; HERBACEOUS AGENT; LISINOPRIL; MAGNESIUM CITRATE; METOPROLOL; MINERAL; NADOLOL; PETASITES HYBRIDUS EXTRACT; PIZOTIFEN; PROPRANOLOL; RIBOFLAVIN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UBIDECARENONE; VALPROATE SEMISODIUM; VENLAFAXINE; VERAPAMIL; VITAMIN;

BODY MASS; CANADIAN HEADACHE SOCIETY; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DRUG EFFICACY; HUMAN; HYPERTENSION; LACTATION; MEDICAL SOCIETY; MIGRAINE; MONOTHERAPY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CANADA; HUMANS; LIFE STYLE; MIGRAINE DISORDERS; SEROTONIN UPTAKE INHIBITORS;

EID: 84857509991     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)